Analystreport

Applied Therapeutics, Inc. (NASDAQ: APLT) had its price target lowered by analysts at Barclays PLC from $64.00 to $44.00.

Applied Therapeutics, Inc.  (APLT) 
Last applied therapeutics, inc. earnings: 11/13 07:00 am Check Earnings Report